Search Result "psychotomimetics"


The NMDA Receptor as a Therapeutic Target in Major Depressive Disorder

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 6 Issue: 2 Year: 2007 Page: 101-115
Author(s): Christopher Pittenger, Gerard Sanacora, John H. Krystal

A Critical Review of the Antipsychotic Effects of Cannabidiol: 30 Years of a Translational Investigation

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 32 Year: 2012 Page: 5131-5140
Author(s): Antonio Waldo Zuardi,Jose Alexandre S. Crippa,Jaime E.C. Hallak,Sagnik Bhattacharyya,Zerrin Atakan,Rocio Martin-Santos,Philip K. McGuire,Francisco Silveira Guimaraes

Inhibition of G Protein-Activated Inwardly Rectifying K+ Channels by Phencyclidine

Journal: Current Neuropharmacology
Volume: 9 Issue: 1 Year: 2011 Page: 244-246
Author(s): Toru Kobayashi, Daisuke Nishizawa, Kazutaka Ikeda

Review Article

Beyond Ketamine: New Approaches to the Development of Safer Antidepressants

Journal: Current Neuropharmacology
Volume: 15 Issue: 7 Year: 2017 Page: 963-976
Author(s): Shigeyuki Chaki

Antidepressant-Like and Anxiolytic-Like Effects of Cannabidiol: A Chemical Compound of Cannabis sativa

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 6 Year: 2014 Page: 953-960
Author(s): Alexandre R. de Mello Schier,Natalia P. de Oliveira Ribeiro,Danielle S. Coutinho,Sergio Machado,Oscar Arias-Carrion,Jose A. Crippa,Antonio W. Zuardi,Antonio E. Nardi,Adriana C. Silva

Essential Structure of the κ Opioid Receptor Agonist Nalfurafine for Binding to the κ Receptor

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 4 Year: 2013 Page: 7400-7414
Author(s): Hiroshi Nagase, Hideaki Fujii

Review Article

Evidences for the Anti-panic Actions of Cannabidiol

Journal: Current Neuropharmacology
Volume: 15 Issue: 2 Year: 2017 Page: 291-299
Author(s): Vanessa P. Soares,Alline C. Campos

Review Article

Therapeutic Modulation of Glutamate Receptors in Major Depressive Disorder

Journal: Current Neuropharmacology
Volume: 15 Issue: 1 Year: 2017 Page: 57-70
Author(s): Brittany A. Jaso, Mark J. Niciu, Nicolas D. Iadarola, Niall Lally, Erica M. Richards, Minkyung Park, Elizabeth D. Ballard, Allison C. Nugent, Rodrigo Machado-Vieira, Carlos A. Zarate

Glutamate and Schizophrenia: Pathophysiology and Therapeutics

Journal: Current Medicinal Chemistry - Central Nervous System Agents
Volume: 2 Issue: 1 Year: 2002 Page: 29-44
Author(s): G. J. Marek

Preclinical Pharmacology of mGlu2 / 3 Receptor Agonists: Novel Agents for Schizophrenia?

Journal: Current Drug Targets - CNS & Neurological Disorders
Volume: 1 Issue: 2 Year: 2002 Page: 215-225
Author(s): Darryle D. Schoepp, Gerard J. Marek

Previous   Next

Go To   Results 1 - 1 of 176

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


Ads
© 2024 Bentham Science Publishers | Privacy Policy